Company intelligence / Profile preview

Embla Medical

Ownership: Private
Employees: ~4078
Development stage: Commercial

Overview

Embla Medical is a global leader in innovative mobility solutions, with over 2,100 patents and award-winning designs. The company operates at commercial scale with strong growth in prosthetics and neuro orthotics segments. Q1 2025 sales reached USD 203 million with an EBITDA margin of 18%. It is recognized for advancing accessibility through its products and patient care clinics[1][3].

Therapeutic areas: OtherRheumatologyNeurology
Modalities: DeviceProstheticsNeuro orthoticsBracing & supports
Industry: Assistive Medical Devices

Partnerships

Össur acquired Fior&Gentz in January 2024

Beyond the preview

Go deeper on Embla Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Embla Medical.

Explore the full profile